POSTER SESSION I Stowell-Orbison/Surgical Pathology/Autopsy Awards Poster
Monday, March 19, 2012   9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
120
Utilization of a TFE3 Break-Apart FISH Assay in a Renal Tumor Consultation Service
(874)
WM Green, GJ Netto, C Griffin, L Morsberger, PB Illei, X Zhou, P Argani - The Johns Hopkins Hospital, Baltimore, MD
Comprehensive Molecular Oncogenomic Profiling & microRNA Analysis of Prostate Cancer
(1008)
S Sethi, D Kong, G Dyson, W Sakr, F Sarkar - Wayne State University, Detroit, MI
Dysregulation of mTOR Pathway in Plasmacytoid Variant of Urothelial Carcinoma of the Urinary Bladder
(868)
ND Gonzalez-Roibon, A Chaux, AO Osunkoya, T Al-Hussain, J Hicks, JI Epstein, GJ Netto - The Johns Hopkins University SOM, Baltimore, MD; Emory University SOM, Atlanta, GA
Differences in TMPRSS2-ERG Gene Fusion, PTEN Deletion, and SPINK1 Overexpression in Prostate Cancer in African- American and Caucasian Men
(912)
F Khani, JM Mosquera, K Park, A Srivastava, AK Tewari, MA Rubin, BD Robinson - Weill Cornell Medical College, New York
Tissue Microarray Analysis of Prostate Cancer Specimens Supports a Positive Feedback Loop among Molecules Involved in Hyaluronan Synthesis, Degradation, and Signaling
(857)
V Ganta, A Rizzardi, L Marston, J Tiffany, R Vogel, N Rosener, G Metzger, J McCarthy, E Turley, S Schmechel - University of Minnesota, Minneapolis, MN
Histopathologic and Clinical Features of Vesical Diverticula
(921)
MX Kong, X Zhao, E Kheterpal, P Lee, S Taneja, J Melamed, F-M Deng - NYU Langone Medical Center, New York, NY; New York University School of Medicine, New York, NY
Primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) Including PUNLMP with Inverted Growth: Outcome Analysis
(1049)
C Wang, JP Maxwell, A Yilmaz, TA Bismar, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, Canada
Renal Lymph Nodes for Tumor Staging: Appraisal of 861 Adult Nephrectomies with Microscopic Examination of Hilar Fat
(948)
V Mehta, JJ Speiser, KM Mudaliar, MM Picken - Loyola Univ Med Ctr, Maywood
Histologic Findings on Prostate Needle Core Biopsies Following Cryotherapy as Monotherapy for Prostatic Adenocarcinoma
(870)
CE Gooden, CK Kovach, PT Nieh, AO Osunkoya - Emory University School of Medicine, Atlanta
BCA2 Is Differentially Expressed in Renal Oncocytoma: An Analysis of 158 Renal Neoplasms
(837)
L Ehsani, A Seth, AO Osunkoya - Emory University School of Medicine, Atlanta; Sunnybrook Health Sciences Center, Toronto, Canada
ERG Expression in Mucinous Prostatic Adenocarcinoma and Prostatic Adenocarcinoma with Mucinous Features: Comparison with Conventional Prostatic Adenocarcinoma
(900)
H Johnson, M Zhou, AO Osunkoya - Emory University School of Medicine, Atlanta; Cleveland Clinic Foundation, Cleveland
ERG vs. Alpha-Methylacyl-CoA Racemase Expression in Histologic Variants of Adenocarcinoma of the Prostate
(872)
S Gottipati, J Hudson, P Humphrey - Washington University, Saint Louis, MO
Telomere Shortening Distinguishes Inverted Papilloma of the Urinary Bladder from Urothelial Carcinoma with Inverted Growth
(1060)
SR Williamson, S Zhang, A Lopez-Beltran, R Montironi, L Cheng - Indiana University School of Medicine, Indianapolis; Cordoba University, Cordoba, Spain; Polytechnic University of the Marche Region (Ancona), Ancona, Italy
Prognostic Relevance of mTORC1 Pathway Components in Papillary Renal Cell Carcinoma
(914)
M Kherad Pezhouh, D Rakheja, RF Yousser, Y Lotan, V Margulis, P Kapur - University of Texas Southwestern Medical Center, Dallas, TX
Evaluation of Erg Expression in Isolated High Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Benign Prostate Glands
(1017)
JN Stall, N Palanisamy, J Siddiqui, AM Chinnaiyan, SA Tomlins, LP Kunju - University of Michigan, Ann Arbor, MI
Impact of Histologic Cystic Features in Clear Cell RCC (CCRCC) and Multilocular Cystic RCC (MCRCC) or Shall We Say – Neoplasm of Low Malignant Potential?
(1031)
M Tretiakova, V Mehta, SS Shen, SJ Sirintrapun, JL Yao, I Alvarado-Cabrero, SE Eggener, AL Shalhav, T Antic, MM Picken, GP Paner - University of Chicago, Chicago; Loyola University Medical Center, Maywood; Methodist Hospital, Houston; Wake Forest University, Winston Salem; University of Rochester, Rochester; National Medical Center, Mexico City, Mexico
Differential Expression of the Transferrin Receptor in Renal Cell Neoplasms: A Novel Marker of Aggressive Behavior
(1011)
NM Shillingford, S Lu, S Mangray, R Tavares, MB Resnick, E Yakirevich - Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI
Subcellular Localization of DC-SCRIPT Correlates with Histologic Type, Grade and Stage of Renal Cell Carcinomas (RCC)
(917)
K-A Kim, JL Garbaini, RN Al-Rohil, CE Sheehan, RP Kaufman, JS Ross, A Hayner-Buchan - Albany Medical College, Albany, NY
Subcellular Localization of Gli-1 Correlates with Histologic Type, Grade and Stage of Renal Cell Carcinoma (RCC)
(783)
RN Al-Rohil, K-A Kim, J Garbaini, CE Sheehan, RP Kaufman, JS Ross, A Hayner-Buchan - Albany Medical College, Albany, NY
CDX-2 Expression in Malignant Germ Cell Tumors of the Testes, Intratubular Germ Cell Neoplasia and Normal Seminiferous Tubules
(930)
MJ Lee, AP Vogt, AO Osunkoya - Emory University School of Medicine, Atlanta
Functional Distinction between the Full-Length Human Androgen Receptor and Its Splicing Variants in Castration- Resistant Prostate Cancer
(891)
R Hu, C Lu, AM De Marzo, WB Isaacs, J Luo - University of Wisconsin, Madison, WI; The Johns Hopkins University, Baltimore, MD
KRAS Mutation Is Present in a Small Subset of Primary Urinary Bladder Adenocarcinomas
(779)
RE Alexander, A Lopez-Beltran, R Montironi, GT MacLennan, GR Chen, KM Post, SA Bilbo, JD Sen, K Meehan, A Cornwell, L Cheng - Indiana University School of Medicine, Indianapolis, IN; Cordoba University, Cordoba, Spain; Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy; Case Western Reserve University, Cleveland, OH; First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China
Renal Cell Carcinoma before and after Sunitinib Therapy. Morphological and Molecular Changes
(835)
R Doshi, M O´Donnell, A Bex, L Beltran, A Sahdev, J Peters, DJ Harrison, GD Stewart, T Powles, DM Berney - Barts Cancer Institute, London, United Kingdom; University of Edinburgh, Edinburgh, United Kingdom; Whipps Cross Hospital, London, United Kingdom; Netherlands Cancer Institute, Amsterdam, Netherlands
MicroRNA Expression Analysis Suggests Genetic Similarity among Urachal Adenocarcinoma Morphologic Variants
(804)
ML Bissonnette, T Stricker, M Tretiakova, R Jimenez, GA Barkan, V Mehta, S Sirintrapun, G Steinberg, K White, G Paner - University of Chicago, Chicago, IL; Mayo Clinic, Rochester, MN; Loyola University Medical Center, Maywood, IL; Wake Forest University, Winston-Salem, NC
Primary Benign Vascular Tumors and Tumor-Like Lesions of the Kidney: A Clinicopathologic Analysis of 16 Cases
(949)
V Mehta, V Ananthanarayanan, T Antic, T Krausz, G Venkataraman, MM Picken - Loyola University Medical Center, Maywood; University of Chicago, Chicago
p63 Imunohistochemistry in Histologic Variants of Urothelial Cell Carcinoma
(919)
J Klapper, G-Q Xiao, PD Unger - The Mount Sinai Medical Center, New York, NY
Pathological Analysis of Testicular Germ Cell Tumor with Metastasis in Retroperitoneal Lymph Nodes
(1026)
WP Tarrant, BA Czerniak, CC Guo - UT MD Anderson Cancer Center, Houston, TX
Decreased Stromal Androgen Receptor Expression in African- Americans with Prostate Cancer
(878)
CS Hale, MX Kong, Q Ren, Y Li, S Krauter, L Chiriboga, I Osman, V Reuter, R Wieczorek, J Melamed, P Lee - NYU Langone Medical Center, New York; Memorial-Sloan Kettering Cancer Center, New York
Non-Invasive Papillary Urothelial Neoplasms of the Bladder: A Study of Tumors with Borderline Features
(968)
JM Oliver-Krasinski, J Hou, LR Harik - Columbia University - New York Presbyterian Hospital, New York, NY
LMP2: An Immunohistochemical Marker for the Differential Diagnosis of Renal Oncocytoma and Chromophobe Renal Cell Carcinoma Eosinophilic Variant
(1073)
G Zheng, A Chaux, R Sharma, G Netto, P Caturegli - Johns Hopkins Hospital, Baltimore, MD
Expression of Parafibromin in Renal Tumors and Its Potential Correlation with Tumor Prognosis
(827)
C Cui, P Lal, Y Ma, JE Tomaszewski, Z Bing - Hospital of the University of Pennsylvania, Philadelphia, PA
Expression of DC-SCRIPT/ZNF366 Protein in Prostatic Adenocarcinomas (PACS): DC-SCRIPT Signaling Is Associated with High Tumor Grage, Advanced Stage and Biochemical Disease Recurrence
(955)
W Mneimneh, BVS Kallakury, GM Sheehan, M Feurstein, CE Sheehan, HAG Fisher, RP Kaufman, T Nazeer, JS Ross - Albany Medical College, Albany, NY; Georgetown University Hospital, Washington, DC
Microsatellite Instability in Prostatic Adenocarcinoma: Association with a Mucinous Phenotype
(855)
CS Friedman, DJ Pisapia, P Ghosh, MM Shevchuk - NYP-Weill Cornell Medical College, New York, NY; NYP- Columbia University Medical Center, New York, NY; Maimonides Medical Center, Brooklyn, NY
Prognostic Relevance of mTORC1 Pathway Components in Chromophobe Renal Cell Carcinoma
(918)
T Kinard, D Rakheja, RF Youssef, Y Lotan, V Margulis, J Sugianto, P Kapur - University of Texas Southwestern, Dallas, TX
Identification and Validation of Immunohistochemical Markers To Discriminate Urothelial Carcinoma Invading the Prostatic Fibromuscular Stroma vs In-Situ Tumor of the Prostatic Ducts
(847)
EJ Fichtenbaum, WL Marsh, DL Zynger - The Ohio State University, Columbus
Intraoperative Frozen Section Evaluation of Ureteral and Urethral Margins: Studies of 212 Consecutive Radical Cystoprostatectomies for Men with Bladder Urothelial Carcinoma
(1078)
H Zhou, JY Ro, LD Truong, AG Ayala, SS Shen - The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX
Microvascular Pericyte Density Predicts Prostate Cancer Progression
(969)
U Ozerdem, EM Wojcik, C Ersahin, GA Barkan - Loyola University Medical Center, Chicago, IL
Utility of Triple Antibody Cocktail Stain in Radical Prostatectomy Specimens with Crushed Surgical Margins
(934)
G Li, N Al Daoud, AJ Evans, TH Van der Kwast - University Health Network, Toronto, Canada; Jordan University of Science and Technology, Irbid, Jordan
Utility of Minichromosome Maintenance Protein 2 (MCM 2) and Topoisomerase II-alpha (TOP2A) Immunohistochemical Staining in the Diagnosis of Neoplastic and Non-Neoplastic Urothelial Lesions
(909)
S Kerkoutian, JY Rao, SK Apple, D Lu, G Galliano, NA Moatamed - University of California Los Angeles, Los Angeles, CA
Sall4 and SF-1 Are Sensitive and Specific Markers for Distinguishing Granulosa Cell Tumors from Yolk Sac Tumors
(793)
S Bai, S Wei, A Ziober, Y Yao, Z Bing - Hospital of the University of Pennsylvania, Philadelphia, PA; University of Alabama at Birmingham, Birmingham, AL
Androgen Receptor in Tumor and Stroma in Conservatively Treated Prostate Cancer
(898)
SS Jeetle, ZH Yang, E Stankiewicz, G Fisher, C Cooper, CS Foster, H Moller, P Scardino, VE Reuter, J Cuzick, D Berney - Barts Cancer Institute, London, United Kingdom; Memorial Sloan-Kettering Cancer Center, New York; Royal Marsden Hospital, Surrey, United Kingdom; Liverpool University Hospital, Liverpool, United Kingdom; Kings College London, London, United Kingdom
Can Positive Surgical Margins (PSM) and Extraprostatic Extension (EPE) in Robot-Assisted Laparoscopic Radical Prostatectomies (RALP) Be Predicted?
(883)
JM Hawkins, RC Heintzelman, J Jaffe, FU Garcia - Drexel University College of Medicine, Philadelphia, PA
Does Increasing Fuhrman Nuclear Grade Reflect Evolving Epithelial-Mesenchymal Transition in Clear Cell Renal Cell Carcinoma?
(824)
JL Conant, Z Peng, MF Evans, S Naud, K Cooper - University of Vermont College of Medicine, Burlington, VT
Correlation between ERG Fusion Protein and Androgen Receptor Expression in Prostate Cancer; Possible Role in Diagnosis and Therapy
(963)
AH Navaei, PP Aung, BA Walter, P Pinto, MJ Merino - NCI/NIH, Bethesda
Zonal Distribution of Neuroendocrine Cells (NECS) within Prostates (PR) with Prostatic Carcinoma (PCA)
(867)
Y Gong, SM Cavone, FU Garcia - Drexel University College of Medicine, Philadelphia, PA
Comparison of mTORC1 Pathway Immunoexpression between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma
(1019)
JZ Sugianto, D Rakheja, RF Youssef, Y Lotan, V Margulis, T Kinard, P Kapur - University of Texas Southwestern Medical Center, Dallas, TX